Acute care in glioblastoma: The burden and the consequences

Neuro-Oncology Practice

Volumn 4, Issue 4, 2017, Pages 248-254

  Wasilewski, Andrea ^a   Serventi, Jennifer ^a   Kamalyan, Lily ^a   Wychowski, Thomas ^a   Mohile, Nimish ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Glioblastoma; Health services; Neuro oncology; Palliative care; Seizures

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CLINICAL OUTCOME; ELECTRONIC MEDICAL RECORD; EMERGENCY CARE; EMERGENCY WARD; FEMALE; GLIOBLASTOMA; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; VENOUS THROMBOEMBOLISM;

EID: 85037149833     PISSN: 20542577     EISSN: 20542585     Source Type: Journal    
DOI: 10.1093/nop/npw032     Document Type: Article

References (31)

1. Osoba D, Brada M, Prados MD, et al. Effect of disease burden on healthrelated quality of life in patients with malignant gliomas. Neuro Oncol. 2000;2(4):221-228.
2. Heimans JJ, Taphoorn MJ. Impact of brain tumour treatment on quality of life. J Neurol. 2002;249(8):955-960.
3. Liu R, Page M, Solheim K, et al. Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol. 2009;11(3):330-339.
4. Stupp R, Mason WP, van den Bent MJ, et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
5. Stupp R, Taillibert S, Kanner AA, et al. maintenance therapy with tumortreating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314(23):2535-2543.
6. Chinot OL, Wick W, Mason W, et al. Bevacizumab plus radiotherapytemozolomide for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):709-722.
7. Arvold ND, Wang Y, Zigler C, et al. Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol. 2014;16(11):1530-1540.
8. El-Jawahri AR, Abel GA, Steensma DP, et al. Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer. 2015;121(16):2840-2848.
9. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015;11(2):145-150.
10. Schilling MB, Parks C, Deeter RG. Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: a retrospective study. Exp Ther Med. 2011;2(5):859-866.
11. Hassett MJ, O'Malley AJ, Pakes JR, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst. 2006;98(16):1108-1117.
12. Joo JD, Kim H, Kim YH, et al. Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution. J Korean Med Sci. 2015;30(11):1597-1603.
13. Sammon JD, McKay RR, Kim SP, et al. Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients. Urology. 2015;85(2):343-349.
14. Wychowski T, Wang H, Buniak L, et al. Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs. Clin Neurol Neurosurg. 2013;115(11):2365-2369.
15. Rosati A, Tomassini A, Pollo B, et al. Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neuro Oncol. 2009;93(3):395-400.
16. Sizoo EM, Braam L, Postma TJ, et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol. 2010;12(11):1162-1166.
17. Klein M, Engelberts NH, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54(4):514-520.
18. Shin JY, Kizilbash SH, Robinson SI, et al. Seizures in patients with primary brain tumors: what is their psychosocial impact? J Neurooncol. 2016;128(2):285-291.
19. Ansari SF, Bohnstedt BN, Perkins SM, et al. Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections. J Neurooncol. 2014;118(1):117-122.
20. Caggiano V, Weiss RV, Rickert TS, et al. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy. Cancer. 2005;103(9):1916-1924.
21. Kuderer NM, Dale DC, Crawford J, et al. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106(10):2258-2266.
22. Silbergeld DL, Rostomily RC, Alvord EC. The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neurooncol. 1991;10(2):179-185.
23. Perry JR. Thromboembolic disease in patients with high-grade glioma. Neuro Oncol. 2012;14 Suppl 4:iv73-iv80.
24. Smith TR, Lall RR, Graham RB, et al. Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period. J Neurooncol. 2014;120(2):347-352.
25. Semrad TJ, O'Donnell R, Zhou H, Wun T, White R. Venous thromboembolism in 9,489 patients with glioma. ASCO Meet Abstr. 2006;24(18_suppl):1538.
26. Gerber DE, Grossman SA, Streiff MB. Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol. 2006;24(8):1310-1318.
27. Sagberg LM, Solheim O, Jakola AS. Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life. J Neurosurg. 2015:1-9.
28. Brooks GA, Abrams TA, Meyerhardt JA, et al. Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014;32(6):496-503.
29. Pompili A, Telera S, Villani V, et al. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients. Neurosurg Focus. 2014;37(6):E5.
30. Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic nonsmall-cell lung cancer. J Clin Oncol. 2012;30(4):394-400.
31. Dubrow R, Darefsky AS. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer. 2011;11(1):325.